Speakers

ALEXANDER LEONARDO SILVA JUNIOR

ALEXANDRA IVO MEDEIROS

ALEXANDRE SALGADO BASSO

ANA MARIA CAETANO FARIA

ANA MARIA MARQUES

ANA PAULA DUARTE DE SOUZA

ANA PAULA JUNQUEIRA-KIPNIS

ANA PAULA LEPIQUE

ANDREAS BAUMLER


ANDRÉ MACEDO VALE

ANDREW POLLARD


ANGELICA THOMAZ VIEIRA

BARBARA FURTADO


BARBARA LUCIA MORAIS DE OLIVEIRA VIEIRA

BARNEY GRAHAM


BURKHARD BECHER


CAMILA INDIANI DE OLIVEIRA

CAROLINA CATTONI KOH

CAROLINE JUNQUEIRA

CLAUDIA IDA BRODSKYN

CRAIG ROY


CRISTINA BONORINO

CRISTINA RIBEIRO DE BARROS CARDOSO

DANIEL DE CARVALHO


DANIELE CARVALHO BERNARDO NASCIMENTO


DANIEL MANSUR

DAN LITTMAN


DARIO S. ZAMBONI

DAVID FURMAN


DENISE MORAIS DA FONSECA

DIEGO CARLOS REIS

DIEGO FALCI


FABIO DE CARVALHO PEIXOTO

FERNANDA CARDOSO

FERNANDA FELICE

FERNANDO Q CUNHA

FLÁVIA MESQUITA


FLÁVIO PROTÁSIO VERAS

GÉRARD EBERL


GUSTAVO GASTÃO DAVANZO

GUSTAVO P. AMARANTE-MENDES

HELDER NAKAYA

HENRIQUE BORGES DA SILVA


IGOR SANTIAGO-CARVALHO

IRIS CASTRO


ISABELLA RAUCH


ISAQUE JOÃO DA SILVA DE FARIA

JEAN-LUC IMLER


JOÃO SANTANA SILVA

JOÃO T. MARQUES

JOÃO VIOLA

JORGE KALIL

JOSÉ CARLOS ALVES-FILHO

JOSÉ LUÍS FACHI

JULIA TEIXEIRA DE CASTRO

KARINA RAMALHO BORTOLUCI

KASSIANA MAFRA BICALHO

KELEN CRISTINA RIBEIRO MALMEGRIM DE FARIAS

KELLY MAGALHÃES

KRIST HELEN ANTUNES

LARISSA CUNHA

LARISSA MARCELY GOMES CASSIANO

LEDA CASTILHO

LETÍCIA DE AQUINO PENTEADO

LÍCIA TORRES

LUCAS CARVALHO

LUCAS D. FAUSTINO


LUCAS RIZZO


LUIS CARLOS DE SOUZA FERREIRA

LUKE O'NEILL


MANOEL BARRAL-NETTO

MARCELO TORRES BOZZA

MARCO ATAIDE

MARCO AURÉLIO RAMIREZ VINOLO

MARCO SAFADI


MARIA REGINA D´IMPÉRIO LIMA

MARTTI ANTILA


MICHAEL T. HENEKA


MONIQUE T. FONSECA

NATÁLIA BRUNETTI SILVA

NAYANE GALDINO


PATRÍCIA T. BOZZA

PAULO HENRIQUE LISBOA RAEDER

PEDRO GAZZINELLI


PEDRO M. M. M. VIEIRA

RAFICK-PIERRE SÉKALY


RAYANE MARTINS BOTELHO

RICARDO GAZZINELLI

RUSSELL VANCE


SERGIO COSTA OLIVEIRA

TAMARA SIVA RODRIGUES

THAÍS DA SILVA RIGONI

THERESA RAMALHO


TIM SPARWASSER


VALÉRIA BORGES

VÂNIA LUIZA DEPERON BONATO

VISHVA M. DIXIT


WALDEREZ DUTRA

ALEXANDER LEONARDO SILVA JUNIOR

Biomédico, Me. em Hematologia

ALEXANDRA IVO MEDEIROS

Endereço para acessar este CV: http://lattes.cnpq.br/8756770929017974 Bolsista de Produtividade em Pesquisa do CNPq - Nível PQ2. Possui graduação em Ciências Biológicas pela Universidade de São Paulo (1994), Mestrado (1998) e Doutorado (2002) em Imunologia Básica e Aplicada na FMRP-USP. Realizou seu Pós-Doutoramento na Faculdade de Ciências Farmacêuticas de Ribeirão Preto (2003-2005). Foi pesquisador PRODOC-CAPES pela Pós-graduação em Imunologia Básica e Aplicada da FMRP-USP (2006-2007). Realizou seu Pós-doutoramento pela University of Michigan (2007-2009), Division of Pulmonary and Critical Care. Atualmente é professor assistente na Faculdade de Ciências Farmacêuticas de Araraquara-UNESP. Atua na área de Imunologia celular nas seguintes áreas de pesquisa: papel imunomodulador da prostanóides na diferenciação de células TCD4+ durante o processo de fagocitose de células apoptóticas e modulação da resposta imune por mediadores lipídicos em infecções pulmonares e intestinais. (Texto informado pelo autor)

ALEXANDRE SALGADO BASSO

Endereço para acessar este CV: http://lattes.cnpq.br/6354870792125973 Graduação em Medicina Veterinária pela Universidade de São Paulo (1995), mestrado (1999) e doutorado (2004) em Patologia Experimental e Comparada pela Universidade de São Paulo. Realizou pós-doutorado no Center for Neurologic Diseases, Brigham and Women's Hospital, Harvard Medical School entre 2005 e 2008. Atualmente é Professor Adjunto do Departamento de Microbiologia, Imunologia e Parasitologia da Escola Paulista de Medicina, Universidade Federal de São Paulo (UNIFESP). Tem experiência na área de Neuroimunologia e Neuroimunomodulação. (Texto informado pelo autor)

ANA MARIA CAETANO FARIA

Endereço para acessar este CV: http://lattes.cnpq.br/2268635568464108 Possui graduação em Medicina pela Universidade Federal de Minas Gerais (1984), mestrado em Microbiologia pela Universidade Federal de Minas Gerais (1989), doutorado em Imunologia pela Universidade de São Paulo (1994) e pós-doutorado pela Harvard Medical School, Boston, EUA (1998-1999 e 2003). Foi Pesquisadora Visitante na Universitá di Bologna, Itália entre setembro 2001 a fevereiro 2012. Foi membro da diretoria da Sociedade Brasileira de Imunologia, SBI (2011-2013), da Câmara de Assessoramento de Ciências Biológicas e Biotecnologia da FAPEMIG (2011-2013) e foi membro do Comitê de Acessoramento de Imunologia do CNPq (2012-2015). Atualmente é Professora Titular de Imunologia da Universidade Federal de Minas Gerais. Tem experiência na área de Imunologia, com ênfase em Imunobiologia, atuando principalmente nos seguintes temas: Imunologia de Mucosas, Imunobiologia da Nutrição, Tolerância oral, Imunobiologia do Envelhecimento. (Texto informado pelo autor)

ANA MARIA MARQUES

ANA PAULA DUARTE DE SOUZA

ANA PAULA JUNQUEIRA-KIPNIS

ANA PAULA LEPIQUE

Endereço para acessar este CV: http://lattes.cnpq.br/0808439926941946 raduada em Ciências Biológicas pela Universidade de São Paulo (1992), mestrado em Ciências Biológicas (Bioquímica) pela Universidade de São Paulo (1996) e doutorado em Ciências Biológicas (Bioquímica) pela Universidade de São Paulo (2000). Atualmente é docente no Departamento de Imunologia, no Instituto de Ciências Biomédicas, USP. Tem experiência na área de Imunologia tumoral,buscando compreender como sinais disparados por tumores influenciam a apresentação de antígenos e consequente a resposta adaptativa anti-tumoral. (Texto informado pelo autor)

ANDREAS BAUMLER

Bibliography: 1989-1992 Doktor der Naturwissenschaften (Ph.D.), Microbiology, Eberhard-Karls-Universität, Tübingen, Germany 1992-1995 Post-Doctoral Fellow, Department of Molecular Microbiology and Immunology, Oregon Health Sciences University, Portland, OR 1995-1996 Research Assistant Professor, Dept. Mol. Microbiol. & Immunol., OHSU, Portland, OR 1996-2001 Assistant Professor, Dept. Med. Microbiol. & Immunol., Texas A&M University SHSC, College Station, TX 2001-2005 Associate Professor, Dept. Med. Microbiol. & Immunol., Texas A&M University SHSC, College Station, TX 2005-present Professor, Dept. Med. Microbiol. & Immunol., University of California at Davis, Davis, CA, 2010 Elected to Fellowship in the American Academy of Microbiology 2020 Elected to Fellowship in the German National Academy of Sciences (Leopoldina)

ANDRÉ MACEDO VALE

ANDREW POLLARD

Professor Pollard is Director of the Oxford Vaccine Group in the Department of Paediatrics at the University of Oxford and an honorary consultant paediatrician at Oxford Children’s Hospital and Fellow of St Cross College. He received a knighthood in the Queen’s Birthday Honours in 2021 for services to Public Health, especially in the pandemic. His research includes the design, development and clinical evaluation of vaccines including those for typhoid, meningococcus, Haemophilus influenzae type b, pneumococcus, plague, pertussis, influenza, rabies, coronavirus and Ebola, and leads studies using a human challenge model of paratyphoid and typhoid. He runs surveillance for invasive bacterial diseases and studies the impact of pneumococcal vaccines in children in Nepal and leads a project on burden and transmission of typhoid in Nepal, Bangladesh and Malawi, and co-leads typhoid vaccine impact studies at these sites. He was the chief investigator for the clinical trials of the Oxford-AstraZeneca vaccine in 2020 in 24,000 participants in UK, South Africa and Brazil, which led to authorisation of the vaccine for use in more than 170 countries with over 550million doses distributed by July 2021. He has supervised 37 PhD students and his publications includes over 500 manuscripts and books on various topics in paediatrics and infectious diseases. He chairs the UK Department of Health and Social Care’s Joint Committee on Vaccination and Immunisation, is a member of WHO’s Strategic Advisory Group of Experts. He chaired the European Medicine’s Agency scientific advisory group on vaccines for 8 years until 2020. He received the “Science Honor and Truth Award” of the Instituto de Patologia en la Altura in La Paz, Bolivia in 2002, the Bill Marshall Award of the European Society for Paediatric Infectious Disease (ESPID) in 2013, the ESPID Distinguished Award for Education and Communication in 2015 and the Rosén von Rosenstein medal in 2019 awarded by the Swedish Paediatric Society and the Swedish Society of Medicine. He was elected to the Academy of Medical Sciences in 2016 and is an NIHR Senior Investigator. He received the Oxford University Vice Chancellor’s Innovation Award in 2020 for his work on typhoid vaccines. He made the first British ascent of Jaonli (6632m) in 1988 and Chamlang in 1991 (7309m) and was the Deputy leader of the successful 1994 British Medical Everest Expedition.

ANGELICA THOMAZ VIEIRA

BARBARA FURTADO

BARBARA LUCIA MORAIS DE OLIVEIRA VIEIRA

BARNEY GRAHAM

BURKHARD BECHER

CAMILA INDIANI DE OLIVEIRA

Endereço para acessar este CV: http://lattes.cnpq.br/5692825410779014 Possui graduação em Ciências Biológicas pela Universidade de São Paulo (1995) e doutorado em Ciências (Biologia da Relação Patógeno-Hospedeiro) pela Universidade de São Paulo (2000). É professora permanente dos cursos de pós-graduação em Patologia (UFBA-FIOCRUZ) e em Ciências da Saúde (UFBA) e professora adjunta da Fundação Bahiana Para o Desenvolvimento das Ciências. Tem experiência em Protozoologia Parasitária Humana e Leishmaniose e se dedica a estudar a interação Leishmania-Hospedeiro-Vetor. Em 2011 foi indicada a membro afiliado da Academia Brasileira de Ciências. Atualmente é Vice Diretora de Pesquisa do Instituto Gonçalo Moniz- FIOCRUZ. (Texto informado pelo autor)

CAROLINA CATTONI KOH

CAROLINE JUNQUEIRA

CLAUDIA IDA BRODSKYN

Endereço para acessar este CV: http://lattes.cnpq.br/8510726976369443 Possui graduação em Biomedicas pela Universidade Federal de São Paulo (1979), mestrado em Imunologia pela Universidade de São Paulo (1989) e doutorado em Imunologia pela Universidade de São Paulo (1996). Atualmente é Professor Titular da Universidade Federal da Bahia e Pesquisador Titular do Instituto Gonçalo Moniz, FIOCRUZ-Bahia.Exerece o mandato da presidência da Sociedade Brasileira de Imunologia no biênio 2018-2019. Tem experiência na área de Imunologia, com ênfase em Imunoparasitologia, atuando principalmente nos seguintes temas:imunidade inata e adaptativa, imunoregulação, Leishmania amazonensis, Leishmania chagasi, Leishmania braziliensis . (Texto informado pelo autor)

CRAIG ROY

CRISTINA BONORINO

CRISTINA RIBEIRO DE BARROS CARDOSO

DANIEL DE CARVALHO

Dr. De Carvalho is a renowned expert in cancer epigenomics and leads a research group at the Princess Margaret Cancer Centre and the University of Toronto. He is a pioneer in the use of cancer epigenetics combined with advanced computational approaches for developing novel liquid biopsy tools applied to cancer early detection, classification and monitoring therapy response. Dr. De Carvalho have published over 70 high profile research papers, many of those featured in prestigious scientific journals such as Nature, Science, Cell, Nature Medicine, Cancer Cell among others and was an invited speaker to over 120 talks worldwide, including such prestigious venues as the Opening plenary lecture at AACR annual meeting. For his scientific contributions, Dr. De Carvalho received numerous awards including the Canadian Cancer Society Bernard and Francine Dorval Prize, Canadian Institutes of Health Research (CIHR) Early Career Award in Cancer. He received the Canada Research Chair in Cancer Epigenetics, the Helen M Cooke Endowed Professorship and was elected membership in the 2019 cohort of The Royal Society of Canada. Most recently, Dr. De Carvalho founded and serves as CSO of Adela, a biotech company developing cell-free DNA methylation liquid biopsy technology for cancer early detection, classification and monitoring therapy response”.

DANIELE CARVALHO BERNARDO NASCIMENTO

DANIEL MANSUR

Endereço para acessar este CV: http://lattes.cnpq.br/1218389465274602 Possui graduação em Ciências Biológicas pela Universidade Federal de Minas Gerais (2002). É doutor em Ciências Biológicas (Microbiologia-ênfase em Virologia) pela Universidade Federal de Minas Gerais. Fez pós-doutorado no Imperial College London (2007-2009) tendo como principal interesse sensores de DNA da imunidade inata e o estudo da evasão do sistema imune pelo vírus Vaccinia. Foi pós-doutorando no departamento de Bioquímica e Imunologia da UFMG pesquisando as interações patógeno/hospedeiro na infecção por Dengue.Desde 2010, é Professor Adjunto de Imunologia no Departamento de Microbiologia, Imunologia e Parasitologia (MIP) na Universidade Federal de Santa Catarina. Tem como principal área de atuação a imunidade célula-intrísica e interação vírus-hospedeiro. (Texto informado pelo autor)

DAN LITTMAN

DARIO S. ZAMBONI

DAVID FURMAN

DENISE MORAIS DA FONSECA

DIEGO CARLOS REIS

DIEGO FALCI

FABIO DE CARVALHO PEIXOTO

FERNANDA CARDOSO

FERNANDA FELICE

FERNANDO Q CUNHA

FLÁVIA MESQUITA

FLÁVIO PROTÁSIO VERAS

GÉRARD EBERL

GUSTAVO GASTÃO DAVANZO

GUSTAVO P. AMARANTE-MENDES

Endereço para acessar este CV: http://lattes.cnpq.br/3033400086575581 Gustavo P. Amarante-Mendes é Professor Titular e Vice-Diretor do Instituto de Ciências Biomédicas da Universidade de São Paulo (ICB-USP). Foi Segundo Secretário (2004-2005), Vice-Presidente (2012-2013) e é o atual Presidente (2016-2017) da Sociedade Brasileira de Imunologia. É Vice-Presidente da Federação das Sociedades de Biologia Experimental (FESBE) (2017-2019). Foi Coordenador do Programa de Pós-graduação em Imunologia (2011-2015) e Presidente da Comissão Interna de Biossegurança (2009-2013) do ICB-USP. Possui graduação em Ciencias Biológicas Modalidade Médica pela Universidade de Santo Amaro (1984), mestrado (1989), doutorado (1993) e Livre-docência (2009) em Imunologia pela Universidade de São Paulo. Foi Research Associate no La Jolla Institute for Allergy and Immunology (San Diego, CA) e Visiting Scientist no Department of Genetics, Trinity College Dublin e na Genentech, Inc, uma empresa do grupo Roche. É membro do corpo editorial da Cell Death and Disease, uma revista do grupo NATURE, da Frontiers in Cell and Developmental Biology, faz parte do Editorial Advisory Panel da Biochemical Journal e é um dos Keystone Symposia Programming Consultants, desde 2012. Recebeu várias premiações científicas, entre elas o 2o Prêmio Oncologia Novartis - Saúde Brasil, Nature Review Cancer Award em 2007 (aluno de doutorado Daniel Diniz de Carvalho), Menção Honrosa no Prêmio CAPES de Tese em 2009 (aluno Ricardo Weinlich) e Premio CAPES de Tese em 2010 (aluno Daniel Diniz de Carvalho). Publicou cerca de 70 trabalhos científicos, os quais, em conjunto, apresentam mais do que 2.500 citações. Tem experiência nas áreas de Imunologia, Biologia Celular e Oncologia Experimental, atuando principalmente nos seguintes temas: morte celular, apoptose, sinalização, imunoregulação, oncogenes, leucemia mieloide crônica, melanoma. (Texto informado pelo autor)

HELDER NAKAYA

HENRIQUE BORGES DA SILVA

Henrique Borges da Silva is a Brazilian Immunologist. He has completed his Bachelor degree in Biology from the Univ. Sao Paulo (2005) and completed his PhD in Immunology in the same institution in 2014. Between 2015 and 2020 Dr. Borges da Silva was a postdoctoral fellow at Dr. Steve Jameson’s lab at the University of Minnesota. Currently, Dr. Borges da Silva is an Assistant Professor at the Mayo Clinic Department of Immunology (Arizona). Through work in his laboratory, Dr. Borges da Silva aims to understand how extracellular nucleotides regulate the immune system. Nucleotides are produced by and influence numerous intracellular pathways. In diverse circumstances, however, nucleotides are released into the extracellular environment and are sensed by specific receptors called purinergic receptors. Immune cells are not devoid of this process; many purinergic receptors are expressed by the immune system. The main focus of Dr. Borges da Silva is determining how one of these nucleotides, extracellular ATP (eATP), affects transcriptional, metabolic and functional mechanisms of CD8+ T cells in response to viral infections and cancer. This stems from fundamental discoveries made by Dr. Borges da Silva that showed a crucial role for the eATP purinergic receptor P2RX7 in the establishment of CD8-positive T cell memory.

IGOR SANTIAGO-CARVALHO

IRIS CASTRO

ISABELLA RAUCH

ISAQUE JOÃO DA SILVA DE FARIA

JEAN-LUC IMLER

Jean-Luc Imler, obtained his MSc degree from AgroParisTech in Paris in 1985 and his PhD from Strasbourg university in 1988. He then joined the DNAX Research Institute in Palo Alto, CA, to work on cytokines for his post-doctoral training. Returning to France in 1992, he first worked as a research scientist in the biotech company Transgene, before being appointed Professor of cell biology at the University of Strasbourg. J.-L. Imler is chairman of the CNRS Research Unit “Insect Models of Innate Immunity” and director of the Institute of Molecular and Cellular Biology at the University of Strasbourg. J.-L. Imler’s interests have always been on the molecular and cellular aspects of cell signaling, with a focus on the context of host-pathogen interactions. In 1994, he joined as a group leader the Insect immunity Department at CNRS chaired by Jules Hoffmann to work on the model organism drosophila. There, his group first investigated the regulation of antimicrobial peptide expression by Toll receptors, before switching to the regulation of viral infection in insects. J.-L. Imler and his group have shown that viruses are controlled by the mechanism of RNA silencing in drosophila, but also trigger inducible responses, involving the evolutionarily conserved molecule STING.

JOÃO SANTANA SILVA

JOÃO T. MARQUES

JOÃO VIOLA

JORGE KALIL

JOSÉ CARLOS ALVES-FILHO

JOSÉ LUÍS FACHI

JULIA TEIXEIRA DE CASTRO

KARINA RAMALHO BORTOLUCI

KASSIANA MAFRA BICALHO

KELEN CRISTINA RIBEIRO MALMEGRIM DE FARIAS

KELLY MAGALHÃES

KRIST HELEN ANTUNES

LARISSA CUNHA

https://orcid.org/0000-0002-1290-0263 Dr. Cunha graduated in the University of São Paulo at Dario Zamboni’s lab (2012), trained as a post-doctoral fellow at St Jude Children’s Research Hospital with Dr. Douglas Green (2014-2018) and currently holds an Assistant Professor position at University of São Paulo and a Young Investigator from FAPESP. Her laboratory focuses on the cell biology of innate immune cells, working on how signaling transduction cascades initiate, progress and ultimately regulate the function of innate immune cells upon activation of a primary function such as phagocytosis. This knowledge is used to understand the pathogenesis of inflammatory disorders and the balance between resistance and tolerance to infections. She currently investigates the role of the autophagy machinery, a bonafide mechanism of coping with metabolic stresses, in the regulation of phagocytosis and their consequences in innate immune cells.

LARISSA MARCELY GOMES CASSIANO

LEDA CASTILHO

LETÍCIA DE AQUINO PENTEADO

LÍCIA TORRES

LUCAS CARVALHO

LUCAS D. FAUSTINO

LUCAS RIZZO

Lucas Bortolotto Rizzo has a Bachelor’s degree of Biomedicine from Federal University of Rio Grande do Sul (UFRGS) and a PhD on immunology and psychiatric disorders from Federal University of São Paulo (UNIFESP). He has also four years’ experience on the corporate business helping customers making better choices as a Field Application Specialist (FAS) and Technical Sales Specialist (TSS).

LUIS CARLOS DE SOUZA FERREIRA

LUKE O'NEILL

Luke O’Neill is Professor of Biochemistry in the School of Biochemistry and Immunology, Trinity Biomedical Sciences Institute at Trinity College Dublin, Ireland. He is a world expert on innate immunity and inflammation. His main research interests include Toll-like receptors, Inflammasomes and Immunometabolism. He is listed by Thompson Reuters/ Clarivates in the top 1% of immunologists in the world, based on citations per paper. Professor O'Neill is co-founder of Sitryx, which aims to develop new medicines for inflammatory diseases. Another company he co-founded, Inflazome was recently acquired by Roche. He was awarded the Royal Dublin Society / Irish Times Boyle Medal for scientific excellence, the Royal Irish Academy Gold Medal for Life Sciences, The Society for Leukocyte Biology (SLB) Dolph O. Adams award, the European Federation of Immunology Societies Medal and in 2018 the Milstein Award of the International Cytokine and Interferon Society. He is a member of the Royal Irish Academy, EMBO (European Molecular Biology Organisation) and a Fellow of the Royal Society. Luke also has a passion for communicating science to the public. He has a weekly radio slot on the Pat Kenny show on Newstalk. In 2018 he published with Gill the best-selling ‘Humanology: a scientist’s guide to our amazing existence’ and in 2019 Gill published ‘The Great Irish Science Book’, a Science book for 10-12 year olds. His latest book, also published by Gill is called ‘Never Mind the B#ll*cks Here’s the Science’.

MANOEL BARRAL-NETTO

MARCELO TORRES BOZZA

MARCO ATAIDE

Marco obtained his Bachelor's degree in Biological Sciences in 2009 from the Pontifical Catholic University of Minas Gerais. From 2010 to 2014, Marco developed his master's and doctorate studies, being enrolled in the graduate school of the Biochemistry and Immunology Department at the Federal University of Minas Gerais. Under Prof. Dr. Ricardo Gazzinelli's supervision, he uncovered some molecular and cellular aspects of the innate immune-associated malaria pathogenesis. He has described the importance of the inflammasome activation for the septic shock-like observed during Plasmodium infection. Additionally, one of his doctorate studies unveils the cellular e molecular choreography associated with experimental cerebral malaria. In 2015, Marco started his postdoctoral training by joining the Leukocytes Dynamics lab led by Prof. Dr. Wolfgang Kastenmüller, initially located at the University of Bonn, Germany, and now at the University of Würzburg as part of the Max Planck Research Group – Systems Immunology Institute. Recently, Marco has uncovered an essential piece of the molecular network controlling the CD8+ T cell memory formation. He also has contributed to the development of new insights regarding the immunobiology of invariant T cells. In 2020, Marco returned to Brazil, where he works as a postdoctoral researcher at Prof. Dr. Dario Zamboni at the University of São Paulo Medical School – Ribeirao Preto, exploring cell death dynamics and inflammasome activation in controlling bacterial infections in vivo.

MARCO AURÉLIO RAMIREZ VINOLO

MARCO SAFADI

MARIA REGINA D´IMPÉRIO LIMA

MARTTI ANTILA

MICHAEL T. HENEKA

MONIQUE T. FONSECA

NATÁLIA BRUNETTI SILVA

NAYANE GALDINO

PATRÍCIA T. BOZZA

PAULO HENRIQUE LISBOA RAEDER

PEDRO GAZZINELLI

PEDRO M. M. M. VIEIRA

Pedro M M Moraes Vieira is a doctor of veterinary medicine by the University of Brasilia and a PhD in immunology by the University of Sao Paulo. Currently he is Associated Professor of Immunology at the University of Campinas and a researcher in the field of immunometabolism. He spent five years (2011 / 2016) as a Research Fellow at the Division of Metabolism, Endocrinology and Diabetes of the Beth Israel Deaconess Medical Center in Harvard Medical School. During this time, he worked on understanding the link between systemic physiology and macrophage immunometabolic regulation. Prof. Moraes-Vieira is the head of the Laboratory of Immunometabolism. His areas of interest are immunometabolic regulation of tissue resident macrophages in healthy and disease, such as obesity and auto-immune and inflammatory diseases.

RAFICK-PIERRE SÉKALY

RAYANE MARTINS BOTELHO

RICARDO GAZZINELLI

RUSSELL VANCE

SERGIO COSTA OLIVEIRA

I am a Full Professor of Immunology at the Federal University of Minas Gerais, Brazil and my research interest is focused on defining the role of innate immunity and inflammation during the course of the intracellular bacterial infections. I got my PhD and postdoctoral training at the University of Wisconsin-Madison (USA). Currently, I am member of the Brazilian Academy of Science and member of the World Academy of Sciences (TWAS). So far, I have published more than 210 peer-reviewed articles with more than 10,000 citations. Additionally, I have trained 23 Master's and 24 PhD's students, and 39 Post-doctoral fellows. Complete List of Published Work in My Bibliography: http://www.ncbi.nlm.nih.gov/myncbi/sergio.oliveira.1/bibliography/48868768/public/?sort=date&direction=ascending

TAMARA SIVA RODRIGUES

THAÍS DA SILVA RIGONI

THERESA RAMALHO

TIM SPARWASSER

Tim Sparwasser studied human medicine at the Johannes-Gutenberg-University Mainz and the Ludwig-Maximilians-University Munich (LMU). After his doctorate he continued his research activities at the Institute for Medical Microbiology, Immunology and Hygiene (MIH) at the Technical University of Munich (TUM) and afterwards at the Skirball Institute as Howard Hughes Medical Institute (HHMI) Postdoctoral Fellow in New York. After his habilitation in 2008 he became director of the Institute of Infection Immunology at Twincore (Center for Experimental and Clinical Infection Research) a joint venture of the Hannover Medical School and the Helmholtz Centre for Infection Research. In 2018, he followed a call from the University of Mainz and became director of the Institute of Medical Microbiology and Hygiene (IMMH) after he had declined a corresponding call from the Technical University of Dresden in 2017. Since 2014 he is a council member of the German Society of Immunology (DGfI). Since 2018, he is a member of the steering committee of the Research Center for Immunotherapy (FZI) at the University of Mainz. In 2019 he was elected as German representative to the Council of the International Union of Immunology Societies (IUIS). The main research interests of his laboratory at the Institute of Medical Microbiology and Hygiene are host-pathogen interactions. Sparwasser was one of the first to recognize that microbial DNA sequences containing specific CpG motifs activate cells of the innate immune system and can therefore be used as adjuvants in experimental vaccination approaches. Using novel genetic models, Sparwasser for the first time directly demonstrated the role of so-called regulatory T cells in the prevention of autoimmunity as well as their importance in the adaptive immune response against tumor cells and various pathogens. Since 2010 Sparwasser has been working on the immune modulatory effects of bacterial metabolites and in particular on the metabolism of immune cells to improve immune responses and vaccinations.

VALÉRIA BORGES

CV: http://lattes.cnpq.br/1527671960187811 Possui graduação em Ciencias Biologicas pela Universidade Federal do Rio de Janeiro (1995), mestrado (1998) e doutorado (2002) pelo Instituto de Biofísica Carlos Chagas Filho, UFRJ e pós-doutorado no Program of Cell Biology do National Jewish Medical and Research Center (Colorado, USA) como bolsista da Pew Latin American Fellows Program in the Biomedical Sciences (2003). Atua em pesquisa no Instituto Gonçalo Moniz e atualmente é coordenadora do Programa de Pós-Graduação em Patologia Humana (PgPAT). Vem se dedicando a estudos na área de parasitologia e biologia da inflamação com ênfase na interação vetor-patógeno-célula hospedeira na infecção por Leishmania sp. (Texto informado pelo autor)

VÂNIA LUIZA DEPERON BONATO

Endereço para acessar este CV: http://lattes.cnpq.br/1788319183446276 Graduação em Ciências Biológicas pela Universidade Federal de São Carlos (1992), Mestrado em Imunologia Básica e Aplicada pela Faculdade de Medicina de Ribeirão Preto da Universidade de São Paulo (FMRP-USP) (1995) e Doutorado em Imunologia Básica e Aplicada pela FMRP-USP (1999). Estágio no Instituto Pasteur, Paris, França (1999). Pós-Doutorado no Departamento de Bioquímica e Imunologia da FMRP-USP (2000-2002). Professora Doutora do Departamento de Bioquímica e Imunologia da FMRP-USP (2002-2013). Professora Associada do Departamento de Bioquímica e Imunologia da FMRP-USP (2013-atual) .Ano sabático / pós-doutorado sênior no Twincore - Instituto de Pesquisa em Doenças Infecciosas, em Hannover, Alemanha (2016-2017). Linha de pesquisa: Modulação da resposta inflamatória nos pulmões, com enfoque nas populações de linfócitos CD4+, populações de céulas dendríticas e de macrófagos. (Texto informado pelo autor)

VISHVA M. DIXIT

WALDEREZ DUTRA